Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4029064012 | Belantamab mafodotin | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4029065013 | Belantamab mafodotin (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4800731000052116 | belantamab mafodotin | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Belantamab mafodotin | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
Belantamab mafodotin | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing belantamab mafodotin (medicinal product) | Has active ingredient | True | Belantamab mafodotin | Inferred relationship | Some | 1 |
Belantamab mafodotin only product | Has active ingredient | True | Belantamab mafodotin | Inferred relationship | Some | 1 |
Product containing belantamab mafodotin in parenteral dose form (medicinal product form) | Has active ingredient | True | Belantamab mafodotin | Inferred relationship | Some | 1 |
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Has active ingredient | True | Belantamab mafodotin | Inferred relationship | Some | 1 |
Belantamab mafodotin therapy (procedure) | Direct substance | True | Belantamab mafodotin | Inferred relationship | Some | 1 |
This concept is not in any reference sets